Seminars in Hematology
Volume 46, Issue 4 , Pages 387-393, October 2009

Iron Sequestration and Anemia of Inflammation

  • Tomas Ganz

      Affiliations

    • Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA
    • Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA
    • Corresponding Author InformationAddress correspondence to Tomas Ganz, MD, PhD, CHS 37-055, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1690
  • ,
  • Elizabeta Nemeth

      Affiliations

    • Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA

Anemia of chronic disease, also called anemia of inflammation, is characterized by hypoferremia due to iron sequestration that eventually results in iron-restricted erythropoiesis. During the last decade, the molecular mechanisms of iron sequestration have been found to center on cytokine-stimulated overproduction of the iron-regulatory hormone hepcidin. The inflammatory cytokine interleukin-6 (IL-6) is a particularly prominent inducer of hepcidin, but other cytokines are likely to contribute as well. Hepcidin excess causes the endocytosis and proteolysis of the sole known cellular iron exporter, ferroportin, trapping iron in macrophages and iron-absorbing enterocytes. The supply of iron to hemoglobin synthesis becomes limiting, eventually resulting in anemia. Depending on the details of the underlying disease, other inflammation-related mechanisms may also contribute to anemia.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by Roche Foundation for Anemia Research (RoFAR).

PII: S0037-1963(09)00098-5

doi:10.1053/j.seminhematol.2009.06.001

Seminars in Hematology
Volume 46, Issue 4 , Pages 387-393, October 2009